bioXXmed AG (FRA:T5O)

Germany flag Germany · Delayed Price · Currency is EUR
0.905
+0.005 (0.56%)
Last updated: Apr 29, 2026, 8:01 AM CET
-55.85%
Market Cap 244.68K
Revenue (ttm) 20.49K
Net Income (ttm) -890.91K
Shares Out 271.87K
EPS (ttm) -3.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2
Average Volume 114
Open 0.905
Previous Close 0.900
Day's Range 0.905 - 0.905
52-Week Range 0.005 - 2.750
Beta 5.37
RSI 44.34
Earnings Date Jun 19, 2026

About bioXXmed AG

bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 1
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol T5O
Full Company Profile

Financial Performance

In 2024, bioXXmed AG's revenue was 3,493, a decrease of -79.93% compared to the previous year's 17,404. Losses were -996,907, -95.24% less than in 2023.

Financial Statements

News

There is no news available yet.